Just Biotherapeutics grabs $14 mln
Seattle-based Just Biotherapeutics, which is focused on expanding global access to protein therapeutics, has secured $14 million in Series A2 financing. The Bill & Melinda Gates Foundation led the round with participation from return backers Merck, Lilly Asia Ventures and ARCH Venture Partners.
25 July 2016•1 min read
